0001209191-23-049648.txt : 20230915
0001209191-23-049648.hdr.sgml : 20230915
20230915183032
ACCESSION NUMBER: 0001209191-23-049648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230915
DATE AS OF CHANGE: 20230915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coleman Mark
CENTRAL INDEX KEY: 0001658379
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 231259775
MAIL ADDRESS:
STREET 1: 25 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-15
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001658379
Coleman Mark
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
1
0
0
0
1
Common Stock
2023-09-15
4
M
0
11016
3.67
A
36113
D
Common Stock
2023-09-15
4
S
0
11016
75.1853
D
25097
D
Common Stock
2023-09-15
4
S
0
18572
75.1771
D
403856
I
See Footnote
Stock Option (Right to Buy)
3.67
2023-09-15
4
M
0
11016
0.00
D
2015-09-16
2024-09-16
Common Stock
11016
0
D
Represents an exercise of stock options.
Such transaction was pursuant to a pre-approved 10b5-1 plan.
Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
2023-09-15